Glutamate modulators like memantine act by blocking NMDA receptors in the visual cortex, potentially reducing abnormal neuronal hyperexcitability associated with Visual Snow Syndrome. By dampening excessive glutamatergic neurotransmission, these medications may help attenuate visual static, improve visual processing, and potentially restore more normalized cortical signaling patterns.